• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Delaware Healthcare Fund

+ Add to Watchlist

DLRHX:US

20.61 USD 0.04 0.19%

As of 09:29:30 ET on 09/29/2014.

Snapshot for Delaware Healthcare Fund (DLRHX)

Year To Date: +15.01% 3-Month: +1.83% 3-Year: +29.22% 52-Week Range: 16.54 - 21.03
1-Month: -2.00% 1-Year: +23.34% 5-Year: - Beta vs RGUSH: 0.96

Mutual Fund Chart for DLRHX

No chart data available.
  • DLRHX:US 20.61
  • 1M
  • 1Y
Interactive DLRHX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DLRHX

Delaware Healthcare Fund is an open-end fund incorporated in the USA. The Fund's objective is to maximize long-term capital growth through capital appreciation. The Fund invests at least 80% of its assets in the equity securities of health care companies.

Inception Date: 01-28-2010 Telephone: 1-800-523-1918
Managers: LIU-ER CHEN "NU"
Web Site: www.delawareinvestments.com/co/delaware

Fundamentals for DLRHX

NAV (on 2014-09-29) 20.61
Assets (M) (on 2014-09-29) 441.23
Fund Leveraged N
Minimum Investment 0.00
Minimum Subsequent Investment 0.00

Dividends for DLRHX

Dividend Type Short Term Cap Gain
Dividend Frequency Irreg
Last Dividend Net (on 2013-12-06) 0.32
Dividend Yield (ttm) 2.04

Fees & Expenses for DLRHX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.85
Redemption Fee 0.00
12b1 Fee 0.50
Expense Ratio 1.63

Top Fund Holdings for DLRHX

Filing Date: 07/31/2014
Name Position Value % of Total
Eli Lilly & Co 572,000 34,926,320 8.299%
GlaxoSmithKline PLC 538,000 26,023,060 6.184%
Teva Pharmaceutical Industries 443,000 23,700,500 5.632%
UCB SA 249,785 22,911,314 5.444%
WellPoint Inc 200,000 21,962,000 5.219%
Idenix Pharmaceuticals Inc 800,000 19,536,000 4.642%
Bristol-Myers Squibb Co 341,737 17,298,727 4.111%
Chugai Pharmaceutical Co Ltd 488,300 16,253,621 3.862%
Fresenius Medical Care AG & Co 230,000 15,943,114 3.789%
Quest Diagnostics Inc 250,000 15,275,000 3.630%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil